Clover Health Investments CEO Andrew Toy sold 313,476 shares of common stock on July 1, 2026, for approximately $1.67 million. The transaction was a non-discretionary 'sell to cover' event tied to tax withholding obligations from restricted stock unit vesting, not a shift in executive sentiment. Toy's direct holdings declined by 3.16% to 9,609,825 shares, representing a stake valued at about $51.8 million based on the July 1 closing price of $5.39. The sale came shortly after Clover Health shares reached a multi-year high of $5.59 on June 29, and the company recently reported a 51% year-over-year increase in Medicare Advantage memberships in the first quarter of 2026, driving a 62% revenue jump to $749.2 million.
Clover Health Investments Corp51% YoY increase in Medicare Advantage memberships and 62% revenue jump indicate strong end-customer demand.